Cherng, H., Gerber, D., Nze, C., Bhayani, S., Russler-Germain, D., Alnughmush, A., Hampel, P., Kille, K., Wallace, D., Qualls, D., Merryman, R., Brooks, J., Bock, A., Ramirez, J., Zhang, Y., Chavez, J., Granger, K., Antel, K., Duarte, C., Major, A., Ma, S., Spinner, M., Mackay, A., Hu, B., Rai, M., Spurgeon, S., Lee, B., Doh, J., Brem, E., Altomare, N., Karmali, R., Ryan, R., Tiger, Y. K., Carter, J., Landsburg, D., Thiruvengadam, S., Skarbnik, A., Choi, Y., Bond, D., Samaeekia, R., Ma, H., Tolu, S., Amengual, J., Herrera, A., Pro, B. (2025). Multicenter real-world outcomes in limited stage (LS) diffuse large B-cell lymphoma (DLBCL) treated with abbreviated immunochemotherapy. Blood. https://doi.org/10.1182/blood-2025-471